Utility of a controlled amphetamine withdrawal paradigm among adults who use methamphetamine: A pilot clinical trial

Albertson, TE, Derlet, RW, Van Hoozen, BE (1999) Methamphetamine and the expanding complications of amphetamines. Western Journal of Medicine 170(4): 214–219.
Google Scholar | Medline American Psychiatric Association (2000) Diagnostic and Statistical Manual of Mental Disorders: DSM-IV (4th edn). Washington, DC: American Psychiatric Association.
Google Scholar American Psychiatric Association (2013) Diagnostic and Statistical Manual of Mental Disorders: DSM-5 (5th edn). Washington, DC: American Psychiatric Association.
Google Scholar | Crossref Cantwell, B, McBride, AJ (1998) Self-detoxification by amphetamine dependent patients: A pilot study. Drug Alcohol Dependence 49: 157–163.
Google Scholar | Crossref | Medline Cruickshank, CC, Dyer, KR (2009) A review of the clinical pharmacology of methamphetamine. Addiction 104: 1085–1099.
Google Scholar | Crossref | Medline | ISI DHHS and SAMHSA (2019) Results from the 2019 National Survey on Drug Use and Health: National Findings in: Department of Health and Human Services Substance Abuse and Mental Health Services Administration. Rockville, MD: Office of Applied Studies.
Google Scholar Elkashef, AM, Rawson, RA, Anderson, AL, et al. (2008) Bupropion for the treatment of methamphetamine dependence. Neuropsychopharmacology 33(5): 1162–1170.
Google Scholar | Crossref | Medline Galloway, GP, Buscemi, R, Coyle, JR, et al. (2011) A randomized, placebo-controlled trial of sustained-release dextroamphetamine for treatment of methamphetamine addiction. Clinical Pharmacology & Therapeutics 89(2): 276–282.
Google Scholar | Crossref | Medline Golden, CJ (1978) Stroop Color and Word Test. Wood Dale, IL: Stoelting Co.
Google Scholar Gonzales, R, Mooney, L, Rawson, R (2010) The methamphetamine problem in the United States. Annual Review of Public Health 31: 385–398.
Google Scholar | Crossref | Medline | ISI Gossop, MR, Bradley, BP, Brewis, RK (1982) Amphetamine withdrawal and sleep disturbances. Drug and Alcohol Dependence 10: 177–183.
Google Scholar | Crossref | Medline Hamilton, M (1959) The assessment of anxiety states by rating. British Journal of Medical Psychology 32: 50–55.
Google Scholar | Crossref | Medline | ISI Hamilton, M (1960) A rating scale for depression. Journal of Neurology, Neurosurgery, and Psychiatry 23: 56–62.
Google Scholar | Crossref | Medline | ISI Heinzerling, KG, Shoptaw, S, Peck, JA, et al. (2006) Randomized, placebo-controlled trial of baclofen and gabapentin for the treatment of methamphetamine dependence. Drug and Alcohol Dependence 85(3): 177–184.
Google Scholar | Crossref | Medline | ISI Hong, R, Matsuyama, E, Nur, K (1991) Cardiomyopathy associated with the smoking of crystal methamphetamine. JAMA 265(9): 1152–1154.
Google Scholar | Crossref | Medline Johnson, BA, Roache, JD, Ait-Daoud, N, et al. (2007) Effects of topiramate on methamphetamine-induced changes in attentional and perceptual-motor skills of cognition in recently abstinent methamphetamine-dependent individuals. Progress in Neuro-Psychopharmacology and Biological Psychiatry 31(1): 123–130.
Google Scholar | Crossref | Medline Kosten, TR (1990) Neurobiology of abused drugs: Opioids and stimulants. Journal of Nervous and Mental Disease 178(4): 217–227.
Google Scholar | Crossref | Medline Leshner, AI, Koob, GF (1999) Drugs of abuse and the brain. Proceedings of the Association of American Physicians 111(2): 99–108.
Google Scholar | Crossref | Medline Longo, M, Wickes, W, Smout, M, et al. (2009) Randomized controlled trial of dexamphetamine maintenance for the treatment of methamphetamine dependence. Addiction 105: 146–154.
Google Scholar | Crossref | Medline McGregor, C, Srisurapanont, M, Jittiwutikarn, J, et al. (2005) The nature, time course and severity of methamphetamine withdrawal. Addiction 100: 1320–1329.
Google Scholar | Crossref | Medline Mancino, MJ, Gentry, BW, Feldman, Z, et al. (2011) Characterizing methamphetamine withdrawal in recently abstinent methamphetamine users: A pilot field study. American Journal of Drug and Alcohol Abuse 37(2): 131–136.
Google Scholar | Crossref | Medline Montoya, ID, Vocci, F (2008) Novel medications to treat addictive disorders. Current Psychiatry Reports 10(5): 392–398.
Google Scholar | Crossref | Medline Murray, JB (1998) Psychophysiological aspects of amphetamine-methamphetamine abuse. Journal of Psychology 132(2): 227–237.
Google Scholar | Crossref | Medline | ISI National Association of Counties (NACO) (2005) The meth epidemic in America. Available at: https://www.ojp.gov/ncjrs/virtual-library/abstracts/meth-epidemic-america-two-new-surveys-us-counties-effect-meth-abuse
Google Scholar National Institute on Drug Abuse (NIDA) (2019) Methamphetamine research report. Available at: https://www.drugabuse.gov/publications/research-reports/methamphetamine/overview
Google Scholar Newton, TF, Roache, JD, De La Garza, R, et al. (2006) Bupropion reduces methamphetamine-induced subjective effects and cue-induced craving. Neuropsychopharmacology 31(7): 1537–1544.
Google Scholar | Crossref | Medline Schuckit, M, Daeppen, J-B, Danko, GP, et al. (1999) Clinical implications for four drugs of the DSM-IV distinction between substance dependence with and without a physiological component. American Journal Psychiatry 156: 41–49.
Google Scholar | Crossref | Medline Shearer, J, Wodak, A, Mattick, RP, et al. (2001) Pilot randomized controlled study of dexamphetamine substitution for amphetamine dependence. Addiction 96: 1289–1296.
Google Scholar | Crossref | Medline | ISI Shoptaw, S, Heinzerling, KG, Rotheram-Fuller, E, et al. (2008) Bupropion hydrochloride versus placebo, in combination with cognitive behavioral therapy, for the treatment of cocaine abuse/dependence. Journal of Addictive Diseases 27(1): 13–23.
Google Scholar | Crossref | Medline Shoptaw, S, Huber, A, Peck, JA, et al. (2006) Randomized, placebo-controlled trail of sertraline and contingency management to treatment of methamphetamine dependence. Drug and Alcohol Dependence 85: 12–18.
Google Scholar | Crossref | Medline | ISI Shoptaw, SJ, Kao, U, Heinzerling, K, et al. (2009) Treatment for amphetamine withdrawal. Cochrane Database of Systematic Reviews 2009: CD003021.
Google Scholar Sibanda, NC, Kornhaber, R, Hunt, GE, et al. (2019) Prevalence and risk factors of emergency department presentations with methamphetamine intoxication or dependence: A systematic review and meta-analysis. Issues in Mental Health Nursing 40(7): 567–578.
Google Scholar | Crossref | Medline Sinha, R (2011) New findings on biological factors predicting addiction relapse vulnerability. Current Psychiatry Reports 13(5): 398–405.
Google Scholar | Crossref | Medline Srisurapanont, M, Jarusuraisin, N, Kittirattanapaiboon, P (2005) Treatment of amphetamine withdrawal. The Cochrane Library 2: CD003021.
Google Scholar Tiihonen, J, Kuoppasalmi, K, Föhr, J, et al. (2007) A comparison of aripiprazole, methylphenidate, and placebo for amphetamine dependence. American Journal of Psychiatry 164: 160–162.
Google Scholar | Crossref | Medline | ISI Trevisan, LA, Boutros, N, Petrakis, IL, et al. (1998) Complications of alcohol withdrawal: Pathophysiological insights. Alcohol Health and Research World 22: 61–66.
Google Scholar | Medline Trivedi, MH, Walker, R, Ling, W, et al. (2021) Bupropion and naltrexone in methamphetamine use disorder. New England Journal of Medicine 384: 140–153.
Google Scholar | Crossref | Medline

留言 (0)

沒有登入
gif